Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Suspected Ovarian Carcinoma”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Large-scale testing (Phase 3)Looking for participantsNCT05804370
What this trial is testing

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

Who this might be right for
Ovarian Cancer
NX Development Corp 170
Not applicableUnknownNCT05161949
What this trial is testing

Artificial inTelligence in eNdometriosis-related ovArian Cancer and Precision Surgery in eNdometriosis-related ovArian Cancer

Who this might be right for
Patients With Suspected Ovarian CarcinomaNon Oncological Patients or With Endometriosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 240
Not applicableTemporarily pausedNCT02742428
What this trial is testing

Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer

Who this might be right for
AscitesOvarian Epithelial CancerMalnutrition
Gdynia Oncology Center 40
Testing effectiveness (Phase 2)Study completedNCT00123773
What this trial is testing

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

Who this might be right for
SarcomaMultiple MyelomaTesticular Neoplasms+2 more
AHS Cancer Control Alberta 1,075
Testing effectiveness (Phase 2)Study completedNCT02889900
What this trial is testing

Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer

Who this might be right for
Recurrent Platinum Resistant Ovarian Cancer
AstraZeneca 62
Large-scale testing (Phase 3)Study completedNCT00850772
What this trial is testing

Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Queensland Centre for Gynaecological Cancer 109
Testing effectiveness (Phase 2)Study completedNCT01689714
What this trial is testing

Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma

Who this might be right for
Ovarian CarcinomaRecurrent Endometrial Carcinoma
Endocyte 16
Early research (Phase 1)Looking for participantsNCT07069335
What this trial is testing

A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Boryung Pharmaceutical Co., Ltd 24
Not applicableLooking for participantsNCT06689605
What this trial is testing

Ultrasound-guided Tru-cut Biopsy in Patients with Suspected Ovarian Cancer: Adequacy, Accuracy, Safety and Patient Assessment.

Who this might be right for
Ovarian Cancer
University Hospital Hradec Kralove 30
Not applicableActive Not RecruitingNCT03965481
What this trial is testing

PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer

Who this might be right for
Malignant Ovarian NeoplasmOvarian Carcinoma
M.D. Anderson Cancer Center 21